Published in Dig Dis on March 01, 2017
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature (2006) 9.36
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab (2005) 9.14
Identification of a nuclear receptor for bile acids. Science (1999) 7.81
Bile acids: natural ligands for an orphan nuclear receptor. Science (1999) 7.18
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell (2000) 7.18
TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab (2009) 6.91
Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell (2000) 6.48
The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem (2003) 6.35
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife (2012) 5.18
A G protein-coupled receptor responsive to bile acids. J Biol Chem (2003) 4.76
Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell (1999) 4.76
FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature (2014) 3.34
Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid. Gastroenterology (2014) 3.29
Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev (2010) 2.97
Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis. Gastroenterology (2011) 2.67
Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J Clin Invest (2003) 2.51
Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism. Hepatology (2014) 2.39
Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver. J Clin Invest (2012) 2.33
Pleiotropic roles of bile acids in metabolism. Cell Metab (2013) 2.25
Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology (2004) 2.20
Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype. Hepatology (2014) 2.19
TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab (2011) 2.17
Bile salt transporters. Annu Rev Physiol (2002) 1.94
6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. J Med Chem (2002) 1.85
Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT. Nature (2011) 1.72
The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology (2012) 1.70
The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells. Hepatology (2007) 1.69
Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice. Hepatology (2015) 1.65
A nontumorigenic variant of FGF19 treats cholestatic liver diseases. Sci Transl Med (2014) 1.64
Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum. J Clin Invest (1982) 1.61
Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis. J Hepatol (2015) 1.59
Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities. Am J Physiol Gastrointest Liver Physiol (2010) 1.54
Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts. Hepatology (2013) 1.52
The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. Handb Exp Pharmacol (2011) 1.46
Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition. J Biol Chem (2003) 1.44
Bile acid receptors as targets for drug development. Nat Rev Gastroenterol Hepatol (2013) 1.43
Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs. J Clin Invest (2010) 1.37
The enterohepatic circulation of bile acids in mammals: form and functions. Front Biosci (Landmark Ed) (2009) 1.31
Hepatic transport of bile salts. Semin Liver Dis (2000) 1.31
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus. J Hepatol (2012) 1.29
Organic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: Studies in Oatp1b2-null mice. Hepatology (2010) 1.29
Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism. Arch Biochem Biophys (2005) 1.28
Physiology of bile secretion. World J Gastroenterol (2008) 1.28
Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction. J Virol (2009) 1.23
TGR5 potentiates GLP-1 secretion in response to anionic exchange resins. Sci Rep (2012) 1.23
Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout mice. Hepatology (2015) 1.14
Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight-loss-independent manner. Obesity (Silver Spring) (2013) 1.13
New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond. J Hepatol (2015) 1.12
Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice. Am J Physiol Gastrointest Liver Physiol (2012) 1.12
Vertical sleeve gastrectomy improves glucose and lipid metabolism and delays diabetes onset in UCD-T2DM rats. Endocrinology (2012) 1.09
Autoradiographic and kinetic demonstration of acinar heterogeneity of taurocholate transport. Am J Physiol (1982) 1.08
Intestinal transport and metabolism of bile acids. J Lipid Res (2014) 1.08
Regulation of bile acid biosynthesis. Gastroenterol Clin North Am (1999) 1.07
Molecular mechanisms of hepatic bile salt transport from sinusoidal blood into bile. Am J Physiol (1995) 1.07
Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor-alpha production by monocytes. Hepatology (1992) 1.06
Gender-dependent effect of Gpbar1 genetic deletion on the metabolic profiles of diet-induced obese mice. J Endocrinol (2010) 1.05
Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity. J Pharmacol Exp Ther (1999) 1.04
A proposed nomenclature for bile acids. J Lipid Res (1992) 1.03
Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters. Pflugers Arch (2013) 0.97
Characterization of organic anion-transporting polypeptide (Oatp) 1a1 and 1a4 null mice reveals altered transport function and urinary metabolomic profiles. Toxicol Sci (2011) 0.94
Na(+)-dependent bile acid transport by hepatocytes is mediated by a protein similar to microsomal epoxide hydrolase. Am J Physiol (1993) 0.93
Homo- and hetero-dimeric architecture of the human liver Na⁺-dependent taurocholate co-transporting protein. Biochem J (2012) 0.92
Molecular control of systemic bile acid homeostasis by the liver glucocorticoid receptor. Cell Metab (2011) 0.92
Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study. J Hepatol (2016) 0.91
Loss of organic anion transporting polypeptide 1a1 increases deoxycholic acid absorption in mice by increasing intestinal permeability. Toxicol Sci (2011) 0.88
Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice. Hepatology (2015) 0.88
First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B. J Hepatol (2016) 0.88
Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein-Coupled Bile Acid Receptors. Endocrinology (2015) 0.88
Inhibition of intestinal bile acid transporter Slc10a2 improves triglyceride metabolism and normalizes elevated plasma glucose levels in mice. PLoS One (2012) 0.87
Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release. Br J Pharmacol (2013) 0.87
Study of the transport of thyroid hormone by transporters of the SLC10 family. Mol Cell Endocrinol (2009) 0.84
Organic anion transporting polypeptide 1a1 null mice are sensitive to cholestatic liver injury. Toxicol Sci (2012) 0.84
Vertical sleeve gastrectomy activates GPBAR-1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice. Hepatology (2016) 0.84
The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double-blind, randomized, placebo-controlled trial. Hepatology (2010) 0.81
The ileal bile acid transporter inhibitor A4250 decreases serum bile acids by interrupting the enterohepatic circulation. Aliment Pharmacol Ther (2015) 0.80
Relationship between the microsomal epoxide hydrolase and the hepatocellular transport of bile acids and xenobiotics. Biochem J (1995) 0.79
Organic anion-transporting polypeptide 1a4 (Oatp1a4) is important for secondary bile acid metabolism. Biochem Pharmacol (2013) 0.79
Atypical mechanism of glucose modulation by colesevelam in patients with type 2 diabetes. Clin Med Insights Endocrinol Diabetes (2013) 0.78
Postprandial plasma concentrations of glycine and taurine conjugated bile acids in healthy subjects. Gut (1983) 0.76
Specific inhibition of bile acid transport alters plasma lipids and GLP-1. BMC Cardiovasc Disord (2015) 0.75
Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin. Hepatology (2009) 1.92
Folding defects in P-type ATP 8B1 associated with hereditary cholestasis are ameliorated by 4-phenylbutyrate. Hepatology (2010) 1.76
Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy. Best Pract Res Clin Gastroenterol (2010) 1.35
Natural killer T cells in adipose tissue prevent insulin resistance. J Clin Invest (2012) 1.34
Heteromeric interactions required for abundance and subcellular localization of human CDC50 proteins and class 1 P4-ATPases. J Biol Chem (2010) 1.20
Molecular determinants in TRPV5 channel assembly. J Biol Chem (2004) 1.05
Regulation of the epithelial Ca2+ channel TRPV5 by the NHE regulating factor NHERF2 and the serum and glucocorticoid inducible kinase isoforms SGK1 and SGK3 expressed in Xenopus oocytes. Cell Physiol Biochem (2004) 0.92
Homo- and hetero-dimeric architecture of the human liver Na⁺-dependent taurocholate co-transporting protein. Biochem J (2012) 0.92
IgG4-associated cholangitis: a comprehensive review. Clin Rev Allergy Immunol (2015) 0.91
Conditional fast expression and function of multimeric TRPV5 channels using Shield-1. Am J Physiol Renal Physiol (2008) 0.89
Monitoring bile acid transport in single living cells using a genetically encoded Förster resonance energy transfer sensor. Hepatology (2013) 0.89
Characterization of a Madin-Darby canine kidney cell line stably expressing TRPV5. Pflugers Arch (2005) 0.87
Requirement of PDZ domains for the stimulation of the epithelial Ca2+ channel TRPV5 by the NHE regulating factor NHERF2 and the serum and glucocorticoid inducible kinase SGK1. Cell Physiol Biochem (2005) 0.85
Biochemical and cellular functions of P4 ATPases. Biochem J (2010) 0.85
Fucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and Crohn's disease--a comprehensive review. Clin Rev Allergy Immunol (2015) 0.84
Analysis of aberrant pre-messenger RNA splicing resulting from mutations in ATP8B1 and efficient in vitro rescue by adapted U1 small nuclear RNA. Hepatology (2015) 0.79
Quantifying stickiness: thermodynamic characterization of intramolecular domain interactions to guide the design of förster resonance energy transfer sensors. Biochemistry (2014) 0.76
IgG4-associated cholangitis. Dig Dis (2014) 0.75
Mutational analysis of ATP8B1 in patients with chronic pancreatitis. PLoS One (2013) 0.75
Hepatic uptake of conjugated bile acids is mediated by both NTCP and OATPs and modulated by intestinal sensing of plasma bile acid levels in mice. Hepatology (2017) 0.75